72 volunteers will be selected for phase 1 and 360 for phase 2. If the results are satisfactory, phase 3 will be carried out with 4,000 to 5,000 participants.
Those interested in participating must be aged 18–50, be healthy, and display symptoms of the disease having started at least four days prior.
At the center, it will be possible to carry out tests of vaccines against covid-19 produced with national technology and developed by researchers from public universities.
Português 
Español 
